SQUAMOUS NSCLC

Clinical trials for SQUAMOUS NSCLC explained in plain language.

Never miss a new study

Get alerted when new SQUAMOUS NSCLC trials appear

Sign up with your email to follow new studies for SQUAMOUS NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

New Three-Drug cocktail aims to fight tough lung cancer

Disease control Not yet recruiting

This study tests whether adding an experimental drug called HLX07 to standard immunotherapy and chemotherapy helps people with advanced squamous non-small cell lung cancer. About 720 adults with stage 3B/4 disease will receive either the new combo or a placebo with standard treat…

Matched conditions: SQUAMOUS NSCLC

Phase: PHASE2, PHASE3 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control

Last updated Jun 27, 2026 08:08 UTC

SQUAMOUS NSCLC

Get alerted when new SQUAMOUS NSCLC trials appear

New Three-Drug cocktail aims to fight tough lung cancer